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ABSTRACT 
Objective: The current study was done to analyze qualitatively the presence of pharmacological compounds and the antibacterial activity of 
different extracts of Indigo feraarrecta. 
Methods: The plant was extracted using hydromethanolic solvent. The extracted compounds were dissolved in different solvents according to their 
polarity and then concentrated using a rotar vapor with a water bath at 40oC. The antibacterial assessment was done using well diffusion method 
and the phytochemicals analysed using standard procedures with minor adjustments.  
Results: The study demonstrated thatthe plant contains very important pharmacological compounds. The extracts tested had different inhibitions 
on the microorganisms tested. Ethyl acetate extract inhibited the growth of all the selected pathogenic organisms while the water extract inhibited 
the growth of three out of the five microorganisms tested. Hexane and butanol inhibited only Bacillus cereus out of the five microorganisms used in 
the study. The penicillin which was used as the positive control inhibited the growth of all the organisms, while dimethylsulfoxide(DMSO) did not 
inhibit the growth of any of the organisms.. One-way analysis of variance (ANOVA) showed there was significant difference in the microorganisms 
zones of inhibition (P<0.05).  
Conclusion: The results obtained in this research are a scientific justification of the plant’s use in the treatment of various diseases. The results have 
revealed thatthe plant has great potency in the treatment against infections caused by all the bacteria tested. However, further research needs to be 
done to isolate the active compounds, identify their structural formula, their mode of action and their effect in the in vivo environment.  
Keywords: Phytochemical, Antibacterial, Plants, Indigo feraarrecta, Medicine. 
 
INTRODUCTION 
The use of plants as a source of medicine is as old as man himself. 
Plants have been used since time immemorial to treat against 
various diseases affecting human beings all over the world. Before 
the invention of synthetic drugs traditional medicine dominated the 
world. Studies by WHO have shown that a large number of 
individuals are using medicinal plants for treatment even today. The 
results obtained shows that the number is also increasing among the 
young people all over the world [1]. It is estimated that 80% of the 
population in developing world use traditional medicines which 
mainly consists of plants for their basic health care [2]. This could be 
attributed to poverty in these countries which makes many people 
unable to access modern hospitals and purchase aliphatic drugs for 
treatment. It is due to this reason that many people turn to plants 
which are believed to be non-toxic, readily available and affordable 
to the local population [3].  
The continued emergence of drug resistant microorganisms has 
always been a concern to scientists and pharmaceutical companies. 
Drug resistant microorganisms have also been an economic concern 
with impacts of them being felt by pharmaceutical companies, 
patients, medical practioners and the public [4]; however plants 
have provided an alternative by providing a source of active 
compounds which have been used as drugs. The invention of active 
antibiotic compounds from plants has increased the interest on the 
study of plants as a source of new antibiotics [5&6]. 
The genus Indigofera contains 700 species of plants which belong to 
the family Fabaceae. The plants in this genus are mainly found in the 
tropical and sub-tropical regions all over the world [2]. Various 
species of the genus Indigofera are used for the production of the 
dye indigo, treatment against epilepsy, liver disease, bronchitis, 
psychiatric illness, anticancer therapy and anti- inflammatory 
activity [7-9].  
The plants of this genus also have antitumor activity [10]. The plant 
Indigoferaarrecta is used to relieve ulcer pain. The plant is used 
traditionally to treat against stomach problems in many 
communities in Kenya such as the Kamba and the Nandi 
communities. The current study was done to determine the 
antibacterial activity of different extracts of Indigo feraarrecta leaves 
and the phytochemicals present in the plant.  
MATERIALS AND METHODOLOGY 
Sample Collection and Preparation:  
The herb was randomly collected in the natural forest around University 
of Eastern Africa, Baraton. The plant samples were identified by a 
taxonomist in the University of Eastern Africa, Baraton. They were then 
thoroughly mixed and spread to dry at room temperature in the 
chemistry laboratory for about three weeks and ground into fine 
powder. The samples were stored intransparent polythene bags. 
Extraction procedure 
Using electric analytical beam balance 100 grams of the powdered 
samples were placed in 500 ml* conical flask, methanol and water 
were then added in the ratio of 9:1 respectively until the samples 
were completely submerged in the solvent. The mixture was then 
agitated for thorough mixing and kept for 24 hours with frequent 
shaking for effective extraction of the plant components. The extract 
was filtered using Butchner funnel; Whatman no.1 filter paper and a 
vacuum and pressure pump. The filtrate was re-filtered again using 
the same apparatus. The solvent was evaporated using rotary 
vacuum evaporator (R-11) with a water bath at 40oC. The crude 
extract was then fractionated into different solvents in order to 
separate the compounds according to polarity using chloroform, 
ethyl acetate, water and then butanol. The fractions where then 
concentrated and the residues obtained stored at 40C for the study. 
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Qualitative phytochemical analysis 
The extracts phytochemical analysis for identification of bioactive 
chemical constituents was done using standard procedures with 
minor adjustments [11-13]. 
Tannins 
About 0.5 g of the sample was put in a test tube and 20 ml of distilled 
water was added and brought to boil. The mixture was then filtered 
and 0.1 % of FeCl3 was added to the filtrate and observations made. 
A brownish green color or a blue-black coloration indicated the 
presence of tannins. 
Saponins 
The crude solvent extract was mixed with 5 ml of water and 
vigorously shaken. The formation of stable form indicated the 
presence of saponins. 
Flavonoids 
A portion of the extract solution was added in to a test tube. To the 
test tube 5 ml* of dilute ammonia and 2 ml* of concentrated 
sulphuric acid was added and heated for about 2 minutes. The 
appearance of a yellow color indicated the presence of flavonoids. 
Terpenoids 
The solvent extracts of the plant material was taken in a clean test 
tube, 2 ml of chloroform was added and vigorously shaken, then 
evaporated to dryness. To this, 2 ml of concentrated sulphuric acid 
was added and heated for about 2 minutes. A greyish color indicated 
the presence of terpenoids. 
Glycosides 
Salkowsks’ test  
The solvent extract of the plant material was mixed with 2 ml of 
chloroform and 2 ml of concentrated sulphuric acid was carefully 
added and shaken gently, then observations were made. A red 
brown color indicated the presence of steroidal ring (glycone 
portion of glycoside). 
Alkaloids 
The crude extract was mixed with 1% of HCl in a test tube. The 
mixture was then heated gently and filtered. To the filtrate a few 
drops of Mayers and Wagner’s reagents were added by the side of 




 About 2g of the solvent extract was put in a test tube and 10 ml of 
chloroform added and filtered. Then 2 ml of the filtrate was mixed 
with 2 ml of a mixture of acetic acid and concentrated sulphuric acid. 
Bluish green ring indicated the presence of steroids. 
Phenols 
The plants solvent extract was put in a test tube and treated with a 
few drops of 2% of FeCl3; blue green or black coloration indicated 
the presence of phenols. 
Bioassay study 
Preparation of the Bacterial Suspension 
The turbidity of each of the bacterial suspension was prepared to 
match to a 0.5 McFarland standard, a procedure similar to that used 
by Biruhalem [14] and Donay et al., [15]. The McFarland standard 
was prepared by dissolving 0.5 g of BaCl2 in 50 ml of water to obtain 
a 1% solution of Barium chloride (w/v). This was mixed with 99.5 
ml of 1% sulphuric acid solution. Three – five identical colonies of 
each bacterium was taken from a blood agar plate (Himedia) culture 
and dropped in Mueller Hinton broth (Himedia). The broth culture 
was incubated at 370C for 2 - 6 hours until it achieved turbidity 
similar to the 0.5 McFarland standard. The culture that exceeded the 
0.5 McFarland standard were each adjusted with the aid of a UV 
spectrophotometer to 0.132A0 at a wavelength of 600 nm in order to 
obtain an approximate cell density of 1x108 CFU/ml. 
Preparation of the Extract Concentrations and Antibiotic  
Extracts stoke solutions were prepared by dissolving 500 mg in 1 ml 
of dimethylsulfoxide (DMSO). An antibiotic control was made by 
dissolving 500 mg of penicillin in 1 ml of sterile distilled water. 
DMSO served as a negative control.  
Determination of the bioactivity of the Extract 
Mueller Hinton agar plates were prepared by the manufacturer’s 
instructions. The bacterial suspension was smeared on the media 
and five wells were drilled in each agar plate. Three of the wells 
were filled with the extract dilution and the other wells were filled 
with penicillin and DMSO control respectively. Three plates were 
made for each bacterial organism and extract giving a triplicate 
reading for each microorganism and extract. The plates were labeled on 
the underside and incubated at 370C for between 24 to 48 hours and the 
zones of inhibition measured in millimeters with the aid of a ruler. 
RESULTS AND DISCUSSION 
Bioassay results  
From the Phytochemical analysis the aqua extract was found to 
contain tannins, Saponins, Terpenoids, glycosides, alkaloids and 
phenols but flavonoids and steroids were found to be absent. The 
hexane extract was found to contain tannins, Saponins, flavonoids, 
and steroids but terpenoids, glycosides, alkaloids and phenols. The 
butanol extract was found to contain tannins, saponins, flavonoids, 
glycosides, alkaloids, steroids and phenols but terpenoids were 
found to be absent. The ethyl acetate extract was found to contain 
tannins, Saponins, glycosides, alkaloids and steroids. The extract was 
found not to contain flavonoids, terpenoids and phenols. 
The presence of these compounds in the plant gives it an edge in the 
treatment of various diseases. The presence of tannins in this plant 
may enable it to have astringent property which makes ituseful in 
preventing diarrhea and controlling hemorrhage due to the ability of 
tannins to precipitate proteins, mucus and constrict blood vessels 
[16]. This is the reason why traditional healers use plants reach in 
tannins to treat wounds and burns since they are able to cause blood 
clotting. Some tannins have been reported to inhibit HIV replication 
selectively besides the use of diuretics [17]. T.h.is shows how 
traditionally used medicinal plants rich in tannins can be used to 
control this dangerous disease. Tannins have also shown 
antiparasitic effects [18]. The anticarcinogenic and antimutagenic 
potentials of tannins may be related to their antioxidative property 
which is important in protecting cellular oxidative damage including 
lipid peroxidation. The growth of many fungi, yeast, bacteria and 
viruses have been proven to be inhibited by tannins [19]. 
Terpenoids have shown great potency in the treatment against 
microorganisms. According to Andrew [20], terpenoids have been 
studied in the in vivo environment and found to inhibit the growth of 
various bacteria. They have also shown potency in the treatment 
against Plasmodium falciparum which is the causative agent of 
malaria [21]. Terpenoids have been found to inhibit the growth of 
fungi Candida albicans[22]. 
Flavonoids are known to contain specific compounds called 
antioxidants which protect human, animal and plant cells against the 
damaging effects of free radicals. Imbalance between free radicals 
and antioxidants leads to oxidative stress which has been associated 
with inflammation, autoimmune diseases, cataract, cancer, 
Parkinson’s disease, aging and arteriosclerosis [23]. Alkaloids on the 
other hand have been found to have analgesic, antispasmodic 
activity, antihypertensive effects, anti-malarial activity, anticancer 
and anti-inflammatory activities [24-26]. T.h.e presence of these 
phytochemicals in this plant leaves and based on the data provided 
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in the literature about them gives the plant its great pharmacological 
value.  The ethyl acetate fraction (Table 7) inhibited the growth of all 
the organisms used in the experiment. The highest zones of 
inhibition were observed on Escherichia colifollowed by Bacillus 
cereus, Proteus vulgaris, Serratiamarcescensand Salmonella typhi had 
the least zone of inhibition .  
The positive control inhibited the growth of all the microorganisms 
while the negative control did not show any zones of inhibition 
against the microorganisms. A one-way analysis of variance 
(ANOVA) showed that there was significant difference between the 
zones of inhibition caused by the plant extract against the 
microorganisms and those caused by the positive control. On a 
further analysis using Tukey’s pair wise comparison test, it was 
found that the zones of inhibition of Bacillus cereus(Table 8) were 
significantly higher than those of Proteus vulgaris,Salmonella typhi, 
Serratiamarcescens but significantly lower than those of Escherichia 
coli (p< 0.05). The inhibition zones of Proteus vulgaris were 
significantly lower as compared to those of Escherichia coli (p< 
0.001). However there was no significance difference between the 
zones of inhibition of Proteus vulgaris and those of Salmonella typhi 
and Serratiamarcescens (p > 0.05).  
The inhibition zones of the plant ethyl acetate extract against 
Salmonella typhi were significantly lower than those of Escherichia 
coli but not significant as compared to those of Serratiamarcescens 
while Escherichia colizones of inhibition were significantly higher as 
compared to Serratiamarcescens. The inhibition zones caused by the 
positive control were all significantly higher than those caused by 
the plant extract. 
 
Table 1: Antimicrobial activity of Indigoferaarrecta hexane fraction against selected pathogenic microorganisms 
Microorganisms  Extract mean ±S. E. (mm) Penicillin mean ± S. E. (mm) DMSO Mean ± S. E. (mm) 
Bacillus cereus  13.33 ± 0.882 24.67±0.333 0.00±0.000 
Proteus vulgaris  0.00±0.000 30.33±0.333 0.00±0.000 
Salmonella typhi 0.00±0.000 29.33±0.333 0.00±0.000 
Serratiamarcescens 0.00±0.000 28.33±0.881 0.00±0.000 
Escherichia coli 0.00±0.000 20.33±0.333 0.00±0.000 
Key: S. E.  = Standard error 
 
Table 2: Tukey’s honestly significant difference among micro-organisms using 500mg/l of Indigoferaarrecta chloroform fraction 
Comparison  P-value  Significance  
B. cereusvsP. vulgaris 0.000 S 
B. c.e.reus vs S. typhi 0.000 S 
B. cereus vs S. marcescens 0.000 S 
B. c.e.reus vs E. c.o.li 0.000 S 
B. c.e.reus vs B. c.e.reus control 0.000 S 
P. vulgaris vs S. typhi 1.000 NS 
P. vulgaris vs S. marcescens 1.000 NS 
P. vulgaris vs E. c.o.li 1.000 NS 
P. vulgaris vs P. vulgaris control 0.000 S 
S. typhi vs S. marcescens 1.000 NS 
S. typhi vs E. c.o.li 1.000 NS 
S. typhi vs S. typhi control 0.000 S 
S. marcescens vs E. c.o.li 1.000 NS 
S. marcescens vsS. marcescens control 0.000 S 
E. colivs. E.  coli control 0.000 S 
Key: S- significant, NS – not significant  
 
Table 3: Antimicrobial activity of Indigoferaarrectabutanol fraction against selected pathogenic microorganisms 
Microorganisms  Extract mean ±S. E. (mm) Penicillin mean ± S. E. (mm) DMSO Mean ± S. E. (mm) 
Bacillus cereus  8.33 ± 0.333 22.00±0.577 0.00±0.000 
Proteus vulgaris  0.00±0.000 17.67±1.201 0.00±0.000 
Salmonella typhi 0.00±0.000 20.33±0.333 0.00±0.000 
Serratiamarcescens 0.00±0.000 21.00±0.577 0.00±0.000 
Escherichia coli 0.00±0.000 12.33±0.333 0.00±0.000 
Key: S. E.  = Standard error 
 
The aqua fraction (Table 5) inhibited the growth of Bacillus cereus,, 
Salmonella typhi and Escherichia coli.. Penicillin which was used as 
the positive control inhibited the growth of all the organisms, while 
DMSO which was used as the negative control. The analysis of 
variance showed that there was significant difference in the zones of 
inhibition amongst the microorganisms. A multiple comparison with 
Tukey’s test (Table 6) showed that the zones of inhibition of Bacillus 
cereus were significantly higher than those of all the other organisms 
(p<0.05). The zones of inhibition of Proteus vulgaris were 
significantly lower as compared to those of Salmonella typhi 
(p<0.05), but not significant from those Serratiamarcescens 
(p>0.05). The zones of inhibition of Proteus vulgaris were 
significantly lower than those of Escherichia coli (p<0.001), on the 
other hand the zones of inhibition of Salmonella typhi were 
significantly higher than those of Serratiamarcescens but 
significantly lower than those of Escherichia coli. The inhibition 
zones of Escherichia coli were however, significantly higher than 
those of Serratiamarcescens. The inhibition zones caused by 
penicillin used as the positive control were significantly higher than 
those caused by the plant extract. The hexane extract only inhibited 
the growth of Bacillus cereus. The penicillin which was used as the 
positive control inhibited the growth of all the organisms used in the 
study (Table 1). The negative control (DMSO) did not show any 
zones of inhibition. The one-way analysis of variance showed that 
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there was significant difference between the zones of inhibition 
amongst the microorganisms. T.h.e zones of inhibition of Bacillus 
cereus (Table 2) were significantly high than those of the other 
organisms (p<0.001), while those of Proteus vulgaris were not 
significantly different from those of Salmonella typhi,Escherichia coli 
and those of Serratiamarcescens.  
The zones of inhibition of Salmonella typhi were not significantly 
different from those Serratiamarcescens and Escherichia coli, while 
those of Serratiamarcescens were not significantly different from 
those of Escherichia coli (p>0.05). The positive control significantly 
inhibited the growth of the microorganisms as compared to the 
plant extract. 
 
Table 4: Tukey’s honestly significant difference among micro-organisms using 500mg/l of Indigoferaarrectabutanol fraction 
Comparison  P-value  Significance  
B. cereusvsP. vulgaris 0.000 S 
B. c.e.reus vs S. typhi 0.000 S 
B. cereus vs S. marcescens 0.000 S 
B. c.e.reus vs E. c.o.li 0.000 S 
B. c.e.reus vs B. c.e.reus control 0.000 S 
P. vulgaris vs S. typhi 1.000 NS 
P. vulgaris vs S. marcescens 1.000 NS 
P. vulgaris vs E. c.o.li 1.000 NS 
P. vulgaris vs P. vulgaris control 0.000 S 
S. typhi vs S. marcescens 1.000 NS 
S. typhi vs E. c.o.li 1.000 NS 
S. t.y.phivsS. typhi control 0.000 S 
S. marcescens vs E. c.o.li 1.000 S 
S. m.a.rcescens vs S. marcescens control 0.000 S 
E. c.o.livsE. coli control 0.000 S 
Key: S- significant, NS – not significant  
 
Table 5: Antimicrobial activity of Indigoferaarrecta aqua fraction against selected pathogenic microorganisms 
Microorganisms  Extract mean ±S. E. (mm) Penicillin mean ± S. E. (mm) DMSO Mean ± S. E. (mm) 
Bacillus cereus  19.67± 0.882 26.00±0.577 0.00±0.000 
Proteus vulgaris  0.00±0.000 22.00±0.577 0.00±0.000 
Salmonella typhi 9.33±0.333 29.00±0.577 0.00±0.000 
Serratiamarcescens 0.00±0.000 25.33±1.202 0.00±0.000 
Escherichia coli 16.00±0.577 23.33± 0.577 0.00±0.000 
Key: S. E.  = Standard error 
 
Table 6: Tukey’s honestly significant difference among micro-organisms using 500mg/l of Indigoferaarrectaaqua fraction 
Comparison  P-value  Significance  
B. cereus vsP. vulgaris 0.000 S 
B. c.e.reusvs S. typhi 0.000 S 
B. cereusvs S. marcescens 0.000 S 
B. c.e.reusvsE. c.o.li 0.012 S 
B. c.e.reusvs B. c.e.reus control 0.000 S 
P. vulgarisvs S. typhi 0.000 S 
P. vulgaris vs S. marcescens 1.000 NS 
P. vulgarisvsE. c.o.li 0.000 S 
P. vulgarisvs P. vulgaris control 0.000 S 
S. typhivs S. marcescens 0.000 S 
S. typhivsE. c.o.li 0.000 S 
S. t.y.phivsS. typhi control 0.000 S 
S. marcescensvsE. c.o.li 0.000 S 
S. marcescensvs S. marcescens control 0.000 S 
E. c.o.livs E. coli control 0.000 S 
Key: S= Significance, NS= No significance 
 
Table 7: Antibacterial activity of Ethyl acetate fraction against selected pathogenic microorganisms 
Microorganisms  Extract mean ±S. E. (mm) Penicillin mean ± S. E. (mm) DMSO Mean ± S. E. (mm) 
Bacillus cereus  14.33±0.333 27.00±0.557 0.00±0.000 
Proteus vulgaris  11.67±0.333 24.33±0.333 0.00±0.000 
Salmonella typhi 11.00±0.000 27.67±0.882 0.00±0.000 
Serratiamarcescens 11.33±0.667 29.67±0.333 0.00±0.000 
Escherichia coli 19.67±0.333 18.67±0.333 0.00±0.000 
Key: S. E. – Standard error 
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Table 8: Tukey’s honestly significant difference among micro-organisms using 500mg/l of Indigoferaarrecta Ethyl acetate fraction 
Comparison  P-value  Significance  
B. cereus vsP. vulgaris 0.019 S 
B. c.e.reusvs S. typhi 0.002 S 
B. cereusvs S. marcescens 0.007 S 
B. c.e.reusvs E. c.o.li 0.000 S 
B. c.e.reusvs B. c.e.reus control 0.000 S 
P. vulgarisvs S. typhi 0.989 NS 
P. vulgaris vs S. marcescens 1.000 NS 
P. vulgarisvs E. c.o.li 0.000 S 
P. vulgarisvs P. vulgaris control 0.000 S 
S. typhivs S. marcescens 1.000 NS 
S. typhivsE. c.o.li 0.000 S 
S. t.y.phivsS. typhi control 0.000 S 
S. marcescensvs E. c.o.li 0.000 S 
S. marcescensvs S. marcescens control 0.000 S 
E. c.o.li vs E. coli control 0.000 S 
Key: S= Significance, NS= No significance 
 
The plant leaves butanol extract (Table 3) was found to inhibit the 
growth of Bacillus cereus,however the fraction did inhibit all the 
other organisms the plant was tested against (Table 1). The 
penicillin which was used as the positive control inhibited the 
growth of all the organisms while DMSO which was used as the 
negative control did not inhibit the growth of any of the organisms 
used in this study. A multiple comparison of significance between 
the zones of inhibition of the microorganisms showed there was 
significance difference between the zones of inhibition of various 
organisms. The zones of inhibition of Bacillus cereus (Table 4) were 
significantly higher than those of all the other organisms. The zones 
of inhibition of Proteus vulgaris were not significantly different from 
those of E. c.o.li, S. marcescens and those of Salmonella typhi. The 
zones of inhibition of Salmonella typhi were not significantly 
different from those of E. coli and Serratiamarcescens (p>0.05). The 
inhibition zones of E. c.o.li were not significantly different from those 
of Serratiamarcescens(p>0.05). The inhibition zones caused by the 
plants extracts were significantly lower than those caused by the 
positive control against all the organisms (p<0.001).  
The results obtained in this research show the great potency of the 
plant Indigoferaarrecta to inhibit the growth of all the tested 
microorganisms. However, as it can be observed from the results it 
is clear the compounds in the plant have different polarities with 
high concentration of polar active compounds as evident by high 
activity of the water and ethyl acetate solvents. The current study is 
in conformity with the previous studies since similar species of the 
genus Indigofera have also shown great antibacterial activity. 
Indigoferatinctoriamethanol extract demonstrated a great number of 
active constituents responsible for antibacterial activity. The plant 
demonstrated activity against methicillin sensitive Staphylococcus 
aureus, methicillin resistant S. aureus, Enterococcus species, 
Streptococcus species and Moraxella cataruhalis[27]. According to 
Sospeter [28], the roots of the plant Indigoferalupatana showed 
great activity against Bacillus subtilis, Klebsiella pneumonia, Proteus 
mirabilis,Pseudomonas aeruginosa and Salmonella typhimurium. 
CONCLUSION 
From this study it may be concluded that the antibacterial activity of 
the plant is closely attributed to the presence of the important 
pharmaceutical compounds found in the plant. T.h.e antibacterial 
activity of the plant could be due to synergistic effect of two or more 
compounds in the plant. The data obtained in this research is a 
scientific justification of the plant leaves use in the treatment of 
various diseases affecting human beings. In the future if more 
research could be conducted the plant extract could be useful in 
treatment of infections caused by Bacillus cereus viz posttraumatic 
wounds, self-limited gastroenteritis, burns, surgical wounds 
infections, and ocular infections such as endophthalmitis, corneal 
abscess and panophthalmitis [29&30]. The plant extract could also 
be also be used to treat immunologically compromised patients 
including AIDS and malignant disease victims [31&32]. The plant’s 
ability to inhibit the growth of E. coli is a scientific justification that 
the plant could be used to treat against enteric infections caused by 
the bacteria. The plants extract could also be used to treat against 
gastro-intestinal diseases, ear infections, urinary tract infections and 
wounds infections caused by Proteus vulgaris [33&34].  
Salmonella sp. makes one of the most common food poisoning forms 
all over the world [35]. The data obtained shows that the plant 
leaves extract could be used to treat against food poisoning caused 
by Salmonella typhi. The plant could also be used to treat against 
typhoid, paratyphoid fever, traveler’s diarrhea, gastroenteritis in 
adults and gastroenteritis in children [36]. Indigoferaarrectacouldbe 
a good source of active compounds for a variety of diseases affecting 
human beings in the world today. The plants ability to inhibit the 
growth of Serratiamarcescens shows how the plant could be 
important to treat against the bacteria which according to Okunda 
[37]cause nosocomial urinary tract infections. The inhibition of the 
plant against these bacteria is therefore note worthy since the 
microorganisms have been found to have resistance against most of 
the currently used antibiotics. However, further research needs to 
be done to isolate the active compounds and analyze their structural 
composition, their mode of action and their effect in the in vivo 
environment. 
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